To explore clinical pharmacists' opinions, and their perceived barriers and facilitators, to support clinical research delivery in secondary care.

Abstract

The National Health Service (NHS) is confronted with significant challenges in facilitating clinical research delivery.1�Clinical pharmacists were instrumental in ensuring patient safety while conducting urgent public health studies, such as the RECOVERY trial, during the COVID-19 pandemic.2�Numerous studies have reported the positive impact of pharmacy workforce in supporting clinical research delivery3. However, it remains unclear whether pharmacists are willing to take on this extra responsibility.